Q-Linea Logo

Q-Linea

Develops rapid, automated antimicrobial susceptibility testing for critical infections.

QLINEA | ST

Overview

Corporate Details

ISIN(s):
SE0011527845 (+2 more)
LEI:
549300BXVB4XRM8WSC73
Country:
Sweden
Address:
Dag Hammarskjölds väg 52A, 752 37 Uppsala
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Q-linea is an innovative infection diagnostics company dedicated to developing solutions for time-critical, life-threatening infections like sepsis and combating the global threat of antimicrobial resistance. The company's flagship product is ASTar®, a fully automated system that provides rapid phenotypic Antimicrobial Susceptibility Testing (AST). By significantly reducing the time to diagnosis from days to hours, ASTar enables healthcare providers to make faster, more accurate treatment decisions with targeted antibiotics. This improves patient outcomes, saves lives, and helps reduce healthcare costs. The ASTar system, which has been granted Breakthrough Device designation by the U.S. FDA, is designed for use in clinical laboratories to optimize the diagnostic workflow for infectious diseases.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 18:40
Regulatory News Service
Q-linea announces outcome of rights issue
English 54.2 KB
2025-11-11 18:40
Regulatory News Service
Q-linea offentliggör utfall i företrädesemissionen
Swedish 54.8 KB
2025-10-22 14:30
Prospectus
Q-linea offentliggör prospekt med anledning av företrädesemission
Swedish 50.1 KB
2025-10-22 14:30
Prospectus
Q-linea publishes prospectus in connection with the rights issue
English 49.7 KB
2025-10-22 13:30
Regulatory News Service
Q-linea announces cost efficiency program to accelerate sales and marketing act…
English 51.6 KB
2025-10-22 13:30
Regulatory News Service
Q-linea tillkännager kostnadseffektiviseringsprogram för att accelerera försälj…
Swedish 52.4 KB
2025-10-21 17:00
Post-Annual General Meeting Information
KOMMUNIKÉ FRÅN Extra Bolagsstämma I Q-LINEA AB (PUBL)
Swedish 47.2 KB
2025-10-21 17:00
Post-Annual General Meeting Information
BULLETIN FROM Extraordinary GENERAL MEETING IN Q-LINEA AB (PUBL)
English 47.5 KB
2025-10-20 07:30
Quarterly Report
Swedish 995.0 KB
2025-10-20 07:30
Quarterly Report
English 1.0 MB
2025-10-19 20:55
Board/Management Information
Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-line…
English 43.1 KB
2025-10-19 20:55
Board/Management Information
Stuart Gander utsedd till verkställande direktör och Anders Ljunggren till vice…
Swedish 43.2 KB
2025-09-23 12:56
Major Shareholding Notification
Swedish 10.9 KB
2025-09-18 08:10
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I Q-LINEA AB (PUBL)
Swedish 72.1 KB
2025-09-18 08:10
Pre-Annual General Meeting Information
NOTICE OF EXTRAORDINARY GENERAL MEETING IN Q-LINEA AB (PUBL)
English 73.3 KB

Automate Your Workflow. Get a real-time feed of all Q-Linea filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Q-Linea

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Q-Linea via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-21 James Kathrein Other Other 5,692,547 170,776.41 SEK
2025-05-21 Stuart Gander Other Other 5,000,000 150,000.00 SEK
2025-05-19 Erika Kjellberg Eriksson Other Other 5,000,000 150,000.00 SEK
2025-05-19 Erika Kjellberg Eriksson Other Other 3,234,000 97,020.00 SEK
2023-08-03 Nexttobe AB Other Buy 23,132,612 69,397,836.00 SEK
2023-07-21 Christer Samuelsson Other Other 30,000 90,000.00 SEK
2023-03-14 Christer Samuelsson Other Buy 16,000 141,731.01 SEK
2023-03-13 Christer Samuelsson Other Buy 4,000 41,398.00 SEK
2023-02-28 Jonas Jarvius Other Buy 41,646 437,283.00 SEK
2023-02-28 CFO Akuten AB Other Buy 10,761 112,955.62 SEK

Peer Companies

Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland
AME
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America
DRTS
ANGIODYNAMICS INC Logo
Develops minimally invasive medical devices for vascular and oncology applications.
United States of America
ANGO
Apyx Medical Corp Logo
Develops helium plasma energy devices for cosmetic and surgical markets.
United States of America
APYX
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea
450950
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America
AMIX
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America
BDMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.